Skip to main content

Home

  • About Toolkits

You are here

HIV/AIDS // Microbicides Toolkit
  • Toolkit Sitemap
  • Feedback

HIV Prevention Trials Terms: An Advocates Guide

This fact sheet explains some of the terms used to talk about trials designed to test new HIV prevention tools.

File: 
PDF icon Advocates' Guide to HIV Prevention Trial Terms (71.78k)
External Links: 
HIV Prevention Trials Terms: An Advocate's Guide
Year: 
2017
Organization: 
AVAC
Languages: 
English
Tags: 
Control
blinded
double-blinded
non-inferiority
open-label extension study

Microbicides Toolkit

  • Home
  • About
  • All Resources

Microbicides Toolkit

  • Essential Knowledge
    • The Basics
      • Overview
      • Antiretroviral-Based Prevention
      • Multipurpose Prevention Technologies
    • The Need
    • Status of Microbicide Research
    • Future of Microbicides
    • Useful Links
  • Clinical Research
    • Clinical Research Results
      • Dapivirine ring
      • Tenofovir gel
      • Tenofovir gel (formulated for rectal use)
    • Current and Planned Trials
    • Research Process
      • Research Ethics
      • Community Engagement
      • Safety
      • Adherence
      • Drug Resistance
      • Standards of HIV Prevention and Care
  • Implementation Research
    • Preparing for Introduction
    • Acceptability and Affordability
    • Impact and Cost-effectiveness
    • Access and Delivery
  • Policy and Guidelines
    • Key Resources
    • Guidelines
  • Advocacy and Communication
    • Advocacy
      • Reports
      • Fact Sheets
      • Films
      • Toolkits
      • Additional Resources
    • Communication
  • Training
  • Country Experiences
    • Clinical Research
    • Implementation Research

Search This Toolkit

  • Print Toolkit

This website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Knowledge SUCCESS (Strengthening Use, Capacity, Collaboration, Exchange, Synthesis, and Sharing) Project. Knowledge SUCCESS is supported by USAID’s Bureau for Global Health, Office of Population and Reproductive Health and led by the Johns Hopkins Center for Communication Programs (CCP) in partnership with Amref Health Africa, The Busara Center for Behavioral Economics (Busara), and FHI 360. The contents of this website are the sole responsibility of CCP. The information provided on this website does not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University. Read our full Security, Privacy, and Copyright Policies.

USAID